Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Aurobindo Pharma Limited NSE:AUROPHARMA
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.